PTPRN and neoplasm: Univariate analysis (Table 2) revealed that the advanced pathologic stage (III–IV), tumor stage (T3–T4), regional lymph node (N1–N3), metastasis (M1), and high PTPRN expression were relevant to remarkably shorter OS in LUAD patients (Table 2).